Analyst Ratings for Threshold Pharmaceuticals (THLD)
THLD Rating Summary
THLD Price Target Summary
- Highest: $15.00 (Lazard Capital)
- Lowest: $10.00 (Maxim Group)
- Average: $12.86
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.86 (+124.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/20/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
10.00 (5.00) |
4.46 | 5.72 | 28.25% | Details |
| 11/21/2012 | Brean Capital | New Coverage | Buy (N/A) |
15.00 (N/A) |
4.63 | 5.72 | 23.54% | Details |
| 9/20/2012 | Maxim Group | New Coverage | Buy (N/A) |
10.00 (N/A) |
7.78 | 5.72 | -26.48% | Details |
| 8/24/2012 | Stifel Nicolaus | New Coverage | Buy (N/A) |
13.00 (N/A) |
7.43 | 5.72 | -23.01% | Details |
| 7/10/2012 | William Blair | New Coverage | Outperform (N/A) |
N/A (N/A) |
8.15 | 5.72 | -29.82% | Details |
| 4/2/2012 | Mizuho Securities | New Coverage | Buy (N/A) |
15.00 (N/A) |
8.80 | 5.72 | -35% | Details |
| 4/1/2011 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
1.54 | 5.72 | 271.43% | Details |
